FGF19 and metabolic dysfunction-associated steatotic liver disease: Besides, several studies have also focused on gut microbiota-related effects of drugs that may be effective in treating NAFLD, such as Aldafermin (an analog of the gut hormone FGF19) (52, 53) and the FXR agonist PX104 (54).